LifeMD Statistics
Share Statistics
LifeMD has 43.31M shares outstanding. The number of shares has increased by 9.86% in one year.
| Shares Outstanding | 43.31M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 3.63% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 33.74M |
| Failed to Deliver (FTD) Shares | 51 |
| FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 5.57M, so 12.86% of the outstanding shares have been sold short.
| Short Interest | 5.57M |
| Short % of Shares Out | 12.86% |
| Short % of Float | 16.34% |
| Short Ratio (days to cover) | 12.15 |
Valuation Ratios
The PE ratio is -13.65 and the forward PE ratio is -179.
| PE Ratio | -13.65 |
| Forward PE | -179 |
| PS Ratio | 1.84 |
| Forward PS | 1 |
| PB Ratio | 80.18 |
| P/FCF Ratio | 3232.66 |
| PEG Ratio | n/a |
Enterprise Valuation
LifeMD Inc. has an Enterprise Value (EV) of 266.86M.
| EV / Earnings | -12.96 |
| EV / Sales | 1.75 |
| EV / EBITDA | -32.49 |
| EV / EBIT | -18.42 |
| EV / FCF | 3069.18 |
Financial Position
The company has a current ratio of 1.22, with a Debt / Equity ratio of 5.38.
| Current Ratio | 1.22 |
| Quick Ratio | 1.15 |
| Debt / Equity | 5.38 |
| Total Debt / Capitalization | 84.33 |
| Cash Flow / Debt | 0.47 |
| Interest Coverage | -5.58 |
Financial Efficiency
Return on equity (ROE) is -5.88% and return on capital (ROIC) is -60.6%.
| Return on Equity (ROE) | -5.88% |
| Return on Assets (ROA) | -0.35% |
| Return on Capital (ROIC) | -60.6% |
| Revenue Per Employee | 736.94K |
| Profits Per Employee | -99.50K |
| Employee Count | 207 |
| Asset Turnover | 2.61 |
| Inventory Turnover | 6.85 |
Taxes
| Income Tax | 428.00K |
| Effective Tax Rate | -0.02 |
Stock Price Statistics
The stock price has increased by -27.37% in the last 52 weeks. The beta is 1.23, so LifeMD 's price volatility has been higher than the market average.
| Beta | 1.23 |
| 52-Week Price Change | -27.37% |
| 50-Day Moving Average | 5.25 |
| 200-Day Moving Average | 7.08 |
| Relative Strength Index (RSI) | 47.53 |
| Average Volume (20 Days) | 610.86K |
Income Statement
In the last 12 months, LifeMD had revenue of $152.55M and earned -$20.60M in profits. Earnings per share was $-0.7.
| Revenue | 152.55M |
| Gross Profit | 133.65M |
| Operating Income | -14.49M |
| Net Income | -20.60M |
| EBITDA | -8.21M |
| EBIT | -14.49M |
| Earnings Per Share (EPS) | -0.7 |
Balance Sheet
The company has $33.15M in cash and $18.93M in debt, giving a net cash position of $14.21M.
| Cash & Cash Equivalents | 33.15M |
| Total Debt | 18.93M |
| Net Cash | 14.21M |
| Retained Earnings | -214.27M |
| Total Assets | 72.56M |
| Working Capital | -10.30M |
Cash Flow
In the last 12 months, operating cash flow was $8.82M and capital expenditures -$8.73M, giving a free cash flow of $86.95K.
| Operating Cash Flow | 8.82M |
| Capital Expenditures | -8.73M |
| Free Cash Flow | 86.95K |
| FCF Per Share | 0 |
Margins
Gross margin is 87.61%, with operating and profit margins of -9.5% and -13.5%.
| Gross Margin | 87.61% |
| Operating Margin | -9.5% |
| Pretax Margin | -11.41% |
| Profit Margin | -13.5% |
| EBITDA Margin | -5.38% |
| EBIT Margin | -9.5% |
| FCF Margin | 0.06% |
Dividends & Yields
LFMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -12.32% |
| FCF Yield | 0.04% |
Analyst Forecast
The average price target for LFMD is $12, which is 111.3% higher than the current price. The consensus rating is "Buy".
| Price Target | $12 |
| Price Target Difference | 111.3% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
Stock Splits
The last stock split was on Oct 14, 2020. It was a backward split with a ratio of 1:5.
| Last Split Date | Oct 14, 2020 |
| Split Type | backward |
| Split Ratio | 1:5 |
Scores
| Altman Z-Score | -1.29 |
| Piotroski F-Score | 5 |